Last reviewed · How we verify

NCT05422196

Evaluation of Computer-Guided Secondary Alveolar Cleft Bone Grafting With and Without Platelet-Rich Fibrin

Completed NA Last updated 16 June 2022
What this trial tests

NA trial testing Platelet-rich fibrin in Alveolar Bone Grafting in 12 participants. Completed in 2 June 2022.

Timeline
1 October 2020
Primary endpoint
1 December 2021
2 June 2022

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment12
Start date1 October 2020
Primary completion1 December 2021
Estimated completion2 June 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 9 to 14, any sex, with Alveolar Bone Grafting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at investigating the role of platelet-rich fibrin in alveolar cleft secondary grafting. This grafting is done from the patient's chin using a computer-guided stent that is customized for each patient, and the cleft volume is analysed at first to estimate the needed amount of bone to be harvested.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet-rich fibrin

Trials testing the same drug.

Other recruiting trials for Alveolar Bone Grafting

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05422196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing